BioLineRx Ltd. (TLV:BLRX)
Israel flag Israel · Delayed Price · Currency is ILS · Price in ILA
1.700
-0.100 (-5.56%)
At close: Dec 4, 2025

BioLineRx Ratios and Metrics

Millions ILS. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019 - 2015
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019 - 2015
Market Capitalization
4486415100309192
Upgrade
Market Cap Growth
-69.17%-79.39%314.57%-67.59%60.58%108.80%
Upgrade
Enterprise Value
-187367-65126150
Upgrade
Last Close Price
0.020.060.380.140.430.55
Upgrade
PS Ratio
1.050.8124.01---
Upgrade
PB Ratio
0.691.758.720.561.462.72
Upgrade
P/TBV Ratio
1.477.80-0.982.14189.39
Upgrade
EV/Sales Ratio
-0.8321.22---
Upgrade
Debt / Equity Ratio
0.581.120.880.240.070.35
Upgrade
Asset Turnover
0.280.560.07---
Upgrade
Inventory Turnover
2.193.63----
Upgrade
Quick Ratio
1.901.521.024.855.892.14
Upgrade
Current Ratio
2.091.761.104.875.912.15
Upgrade
Return on Equity (ROE)
-21.23%-69.11%-189.23%-41.96%-60.04%-108.36%
Upgrade
Return on Assets (ROA)
-13.60%-23.28%-38.30%-23.10%-24.07%-28.42%
Upgrade
Return on Capital (ROIC)
-18.24%-44.90%-61.08%-26.82%-30.23%-38.96%
Upgrade
Return on Capital Employed (ROCE)
-38.50%-81.50%-203.40%-44.40%-34.60%-62.60%
Upgrade
Earnings Yield
-22.21%-39.26%-52.59%-87.63%-27.24%-50.16%
Upgrade
FCF Yield
-100.55%-187.02%-19.72%-92.62%-23.83%-38.78%
Upgrade
Buyback Yield / Dilution
-86.44%-24.37%-24.47%-16.75%-162.19%-72.70%
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.